PXMP2 inhibits tumor stemness and immune infiltration in hepatocellular carcinoma based on stemness risk
Abstract Background Hepatocellular carcinoma (HCC) is a complex and heterogeneous disease wherein cancer stem cells (CSCs) play a pivotal role in driving tumorigenesis, metastasis, and resistance to therapy. This study sought to map the stemness landscape of HCC and identify patients who may benefit...
Saved in:
| Main Authors: | Dingde Ye, Jiaqing Chen, Jian Wang, Qing Ge, Xianzhong He, Jiamu Qu, Ting Fang, Runze Wang, Shuai Mao, Qiang Wang, Qingxiang Xu, Beicheng Sun |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2025-06-01
|
| Series: | Discover Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s12672-025-02976-4 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Leveraging diverse cell-death patterns to predict to predict prognosis and immunotherapy in hepatocellular carcinoma
by: Xiaoxiang Zhang, et al.
Published: (2025-08-01) -
Integrated Multi-Omics Profiling Identifies PDZ-Binding Kinase (PBK) as a Novel Prognostic Biomarker in Hepatocellular Carcinoma
by: Zhang J, et al.
Published: (2025-07-01) -
MRI radiomics model for predicting tumor immune microenvironment types and efficacy of anti-PD-1/PD-L1 therapy in hepatocellular carcinoma
by: Rui Zhang, et al.
Published: (2025-07-01) -
Establishment and evaluation cuproptosis-related gene signature for predicting the prognosis and immunotherapy response of hepatocellular carcinoma
by: Shuo Wang, et al.
Published: (2025-04-01) -
Integrative analysis of multi-omics data identified PLG as key gene related to Anoikis resistance and immune phenotypes in hepatocellular carcinoma
by: Xueyan Wang, et al.
Published: (2024-12-01)